Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

PLAINS GP HOLDINGS LP (PAGP)

8-K Exec appointment confidence 85% filed 2026-06-02 Item 5.02

The disclosure centers on Russ Montgomery's promotion to Vice President, Accounting and Chief Accounting Officer effective September 1, 2026, a material executive appointment. While Chris Herbold's retirement is also mentioned, the principal action disclosed is Montgomery's appointment to the chief accounting officer role, a position responsible for financial reporting and accounting oversight. The appointment of a new CAO is material to investors assessing the registrant's financial reporting controls and leadership continuity.

View raw filing on EDGAR →

Cornerstone Building Brands, Inc.

8-K Exec appointment confidence 85% filed 2026-06-02 Item 5.02

Richard Dirkson was appointed as Senior Vice President, Corporate Controller (principal accounting officer) effective May 28, 2026, with a base salary of $360,000, 50% target bonus, and 14,000 Class B Profit Units. The appointment also involved the departure of Tina Beskid as Chief Accounting Officer.

View raw filing on EDGAR →

Salesforce, Inc. (CRM)

8-K Exec appointment confidence 92% filed 2026-06-02 Item 5.02

Guy Wanger was appointed as Chief Accounting Officer and principal accounting officer of Salesforce, effective June 15, 2026. While the disclosure includes compensatory details (base salary of $700,000, 70% bonus target, $2 million sign-on bonus, and $9 million equity award), the principal disclosed action is the appointment of an officer to a key financial role. The appointment of a principal accounting officer is material to investors as it affects the registrant's financial reporting and internal controls oversight.

View raw filing on EDGAR →

ONCOLYTICS BIOTECH INC (ONCY)

8-K Exec appointment confidence 95% filed 2026-06-02 Item 5.02

On June 1, 2026, Oncolytics Biotech appointed John McAdory as Chief Operating Officer and Stephen Glover as a director. These senior leadership appointments represent material changes to the company's governance and management structure.

View raw filing on EDGAR →

Mastercard Inc (MA)

8-K Exec appointment confidence 92% filed 2026-06-02 Item 5.02

The filing discloses multiple executive appointments effective August 3, 2026: Ling Hai appointed as Chief Financial Officer (with detailed compensation including $850,000 base salary and $1,500,000 LTI award), Linda Kirkpatrick appointed as Chief Services Officer, and Craig Vosburg transitioning to Vice Chair. While the section also mentions Sachin Mehra's transition to Chief Business Officer and Timothy Murphy's retirement, the principal disclosed actions center on new appointments to key officer roles, particularly the CFO succession. These are material changes to the Company's executive leadership structure.

View raw filing on EDGAR →

StandardAero, Inc. (SARO)

8-K Exec appointment confidence 92% filed 2026-06-02 Item 5.02

Paul McElhinney was appointed as Chief Executive Officer effective October 1, 2026, and as Chairman effective January 1, 2027. The appointment includes a comprehensive employment agreement with $1.1M base salary, $15M option grant, $5M RSU grant, and severance provisions. Russell Ford's concurrent retirement as CEO and Chairman is disclosed as context for the transition.

View raw filing on EDGAR →

GLADSTONE LAND Corp (LANDO)

8-K Exec appointment confidence 95% filed 2026-06-02 Item 5.02

George "Chip" Stelljes, III was elected to the Board of Directors of Gladstone Land Corporation, effective June 1, 2026, with assignment to three board committees.

View raw filing on EDGAR →

GLADSTONE COMMERCIAL CORP (GOODO)

8-K Exec appointment confidence 95% filed 2026-06-02 Item 5.02

George "Chip" Stelljes, III was elected to the Board of Directors of Gladstone Commercial Corporation, effective June 1, 2026, and assigned to three board committees.

View raw filing on EDGAR →

GLADSTONE CAPITAL CORP (GLAD)

8-K Exec appointment confidence 95% filed 2026-06-02 Item 5.02

George "Chip" Stelljes, III was elected to the Board of Directors of Gladstone Capital Corporation, effective June 1, 2026, and appointed to three Board committees: Compensation, Ethics/Nominating/Corporate Governance, and Valuation.

View raw filing on EDGAR →

GLADSTONE INVESTMENT CORPORATION\DE (GAING)

8-K Exec appointment confidence 95% filed 2026-06-02 Item 5.02

George "Chip" Stelljes, III was elected to the Board of Directors of Gladstone Investment Corporation, effective June 1, 2026, and assigned to three board committees: Compensation, Ethics/Nominating/Corporate Governance, and Valuation.

View raw filing on EDGAR →

ACHIEVE LIFE SCIENCES, INC. (ACHV)

8-K Exec appointment confidence 95% filed 2026-06-02 Item 5.02

The filing discloses the appointment of two new directors, Jeff Farrow and Reid Waldman, M.D., to the Board of Directors effective May 29, 2026, along with their committee assignments. While the section also mentions compensatory arrangements (stock options and retainers), the principal disclosed action is the appointment of these individuals to board roles, making exec_appointment the most salient classification. Board appointments are material to investors as they affect governance and oversight.

View raw filing on EDGAR →

Ardent Health, Inc. (ARDT)

8-K Exec appointment confidence 92% filed 2026-06-02 Item 5.02

Dave Caspers was appointed as President and Chief Executive Officer and Board member of Ardent Health, Inc. effective June 2, 2026, succeeding Martin J. Bonick. The appointment includes an employment agreement and equity grants.

View raw filing on EDGAR →

Cue Biopharma, Inc. (CUE)

8-K Exec appointment confidence 80% filed 2026-06-02 Item 5.02

On June 1, 2026, Cue Biopharma appointed Sumita Ray as Chief Legal & Compliance Officer and Corporate Secretary, Michael Meluzio as Vice President and Principal Accounting Officer, and Daniel Camardo and Viola Meehan as directors. The appointments represent material governance and executive leadership changes, including board restructuring from seven to five directors and committee assignments for the new board members.

View raw filing on EDGAR →

Hub Group, Inc. (HUBG)

8-K Exec appointment confidence 75% filed 2026-06-02 Item 5.02

Todd Heeter was appointed as interim Chief Financial Officer effective May 28, 2026, under a consulting agreement providing $125,000 per month for six months. This appointment follows the departure of Kevin Beth as CFO on May 27, 2026, and Brian Meents as Chief Operating Officer, representing material changes to senior management.

View raw filing on EDGAR →

Dine Brands Global, Inc. (DIN)

8-K Exec appointment confidence 75% filed 2026-06-02 Item 5.02

Lawrence Y. Kim was appointed to the additional position of Chief Commercial Officer effective June 1, 2026. While the disclosure also includes compensatory arrangements (salary increase to $850,000, bonus opportunity of 125%, long-term equity awards of $2,000,000 annually, and a $3,000,000 performance retention grant), the principal disclosed action is the appointment to a new executive officer role. The appointment of an executive to a significant new position is material to investors.

View raw filing on EDGAR →

SOUTHERN FIRST BANCSHARES INC (SFST)

8-K Exec appointment confidence 95% filed 2026-06-02 Item 5.02

The disclosure centers on the appointment of Bryan Kennedy as a director of Southern First Bancshares, Inc. and Southern First Bank effective June 1, 2026, with assignment to the Risk Committee. While the section also mentions his participation in standard director compensation arrangements, the principal action disclosed is his appointment to the board, making this an exec_appointment event. The material nature is supported by Kennedy's extensive banking background, his role as Lead Independent Director of a NYSE-traded company, and the Boards' explicit statement that his experience will enhance the Company's governance.

View raw filing on EDGAR →

Rocket One Inc. (HOTH)

8-K Exec appointment confidence 85% filed 2026-06-02 Item 8.01

The disclosure announces the appointment of Dr. Supriyo Bandyopadhyay as Lead Technical Advisor of AI Nanomagnetic Technology, a senior technical leadership role guiding development of the Company's core nanomagnetic AI chip technology for space and defense markets. This executive appointment is material to investors assessing the Company's technical capability and strategic direction in a key technology area.

View raw filing on EDGAR →

Launch One Acquisition Corp. (LPAAU)

8-K Exec appointment confidence 95% filed 2026-06-02 Item 5.02

The filing discloses the appointment of Daniel Clifford Rogers as a member of the Board and chair of the Audit Committee on June 2, 2026, replacing Dr. Risa Stack. While Dr. Stack's resignation is mentioned, the principal disclosed action centers on Mr. Rogers taking a role—specifically a board seat and audit committee chair position—making this an exec_appointment event. The appointment is material as it involves a change in board composition and audit committee leadership at an acquisition company.

View raw filing on EDGAR →

Picard Medical, Inc. (PMI)

8-K Exec appointment confidence 85% filed 2026-06-02 Item 5.02

The filing discloses the appointment of Georgina Smith as Chief Accounting Officer effective June 1, 2026, with detailed background information on her qualifications and prior roles. While the section also mentions Bernard Skaggs's termination as CFO, the substantive disclosure centers on the appointment of a new accounting officer to a material position. The appointment of a CAO is material to investors assessing the company's financial reporting and internal control infrastructure.

View raw filing on EDGAR →

US Alliance Corp

8-K Exec appointment confidence 75% filed 2026-06-02 Item 5.02

Jeffrey Brown was appointed to multiple senior officer positions on June 1, 2026, including Vice-President and Principal Financial Officer of the parent company and President and Chief Operating Officer of key subsidiaries. While the disclosure includes compensatory details (base salary of $275,000, 100,000 share grant, severance terms), the principal disclosed action is the appointment itself to these material executive roles. The appointment is material to investors as it affects the registrant's senior management structure and financial oversight.

View raw filing on EDGAR →

VisionWave Holdings, Inc. (VWAVW)

8-K Exec appointment confidence 92% filed 2026-06-02 Item 5.02

Mr. Einav Eliraz was appointed Chief Financial Officer of VisionWave IL Ltd. (a wholly-owned subsidiary) effective June 1, 2026, with an employment agreement disclosing his salary, performance bonus eligibility, and a material equity grant of 500,000 options. The filing emphasizes his anticipated significant role in the Company's consolidated financial reporting, SEC compliance, M&A activities, and strategic initiatives across global operations, making this a material executive appointment despite the subsidiary structure.

View raw filing on EDGAR →

Cycurion, Inc. (CYCUW)

8-K Exec appointment confidence 92% filed 2026-06-02 Item 5.02

Ana Garcia was appointed as Chief Financial Officer effective June 1, 2026, with a base salary of $300,000, up to 50% bonus, and a $300,000 RSU award. The appointment also included severance provisions and replaced Alvin McCoy III in the CFO role.

View raw filing on EDGAR →

LOUISIANA-PACIFIC CORP (LPX)

8-K Exec appointment confidence 90% filed 2026-06-01 Item 5.02

Aaron Howald was appointed Chief Financial Officer and Senior Vice President effective September 1, 2026, succeeding Alan Haughie who announced his retirement. The appointment includes substantial compensatory arrangements comprising a $560,000 base salary, 75% incentive target, a $625,000 one-time RSU grant, and $975,000 in annual equity grants.

View raw filing on EDGAR →

WEST PHARMACEUTICAL SERVICES INC (WST)

8-K Exec appointment confidence 95% filed 2026-06-01 Item 5.02

Michel Lagarde was appointed as President and Chief Executive Officer effective August 31, 2026, and appointed to the Board of Directors, replacing retiring CEO Eric M. Green. The filing also discloses compensatory arrangements for Mr. Lagarde as part of this executive succession event.

View raw filing on EDGAR →

MICROCHIP TECHNOLOGY INC (MCHPP)

8-K Exec appointment confidence 95% filed 2026-06-01 Item 5.02

Mitch Little, former Senior Vice President of Microchip, was appointed as a member of the Board of Directors effective June 1, 2026, upon recommendation from the Nominating, Governance and Sustainability Committee. The disclosure centers on the appointment action itself, with Little meeting Nasdaq independence requirements and participating in standard non-employee director compensation. While Little's retirement in 2022 is mentioned contextually, the material event disclosed is his appointment to the Board.

View raw filing on EDGAR →

Magnolia Bancorp, Inc. (MGNO)

8-K Exec appointment confidence 92% filed 2026-06-01 Item 5.02

Robert W. Kimbro was appointed as President and Chief Executive Officer of Magnolia Bancorp, Inc. and its subsidiary effective June 1, 2026, in a material executive succession event. Michael L. Hurley voluntarily relinquished the President and CEO titles concurrent with Kimbro's appointment.

View raw filing on EDGAR →

FS Bancorp, Inc. (FSBW)

8-K Exec appointment confidence 95% filed 2026-06-01 Item 5.02

Matthew D. Mullet was named Chief Executive Officer of FS Bancorp, Inc. effective June 1, 2026, as part of a previously announced CEO succession plan. While the disclosure also mentions Joe Adams' retirement as CEO, the principal action disclosed is Mullet's appointment to the CEO role, making this an executive appointment event. CEO transitions are material to investors as they affect corporate governance and strategic direction.

View raw filing on EDGAR →

FedEx Freight Holding Company, Inc. (FDXF)

8-K Exec appointment confidence 85% filed 2026-06-01 Item 5.02

FedEx Freight appointed a new board of nine directors and six executive officers effective immediately prior to the spin-off completion on May 27, 2026, including John A. Smith as President and CEO, and five other executive officers (Clement Edward Klank III as EVP–Chief Human Resources and Legal Officer, Michael B. Lyons as EVP–Chief Specialized Services and Commercial Officer, Clinton D. McCoy as EVP–Chief Operating Officer, Michael Rodgers as EVP–Chief Technology Officer, and Marshall W. Witt as EVP–Chief Financial Officer) to lead the newly independent company.

View raw filing on EDGAR →

CECO ENVIRONMENTAL CORP (CECO)

8-K Exec appointment confidence 92% filed 2026-06-01 Item 5.02

Following the merger completion, CECO appointed Marcus J. George and Victor L. Richey as new directors to the Board, and elevated Todd Gleason to Chairman, increasing the Board size from eight to ten members.

View raw filing on EDGAR →

DISCIPLINED GROWTH ACQUISITION Corp (DGAC)

8-K Exec appointment confidence 95% filed 2026-06-01 Item 5.02

Five directors—John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman, and Jay Gettenberg—were appointed to the board effective May 27, 2026 in connection with the IPO, with committee assignments made on May 28, 2026.

View raw filing on EDGAR →

Hadron Energy, Inc. (GIGGW)

8-K Exec appointment confidence 85% filed 2026-06-01 Item 5.02

Five executive officers were appointed effective upon the business combination closing on May 22, 2026: Samuel Gibson as CEO, Rahul Shukla as CFO, Ken Canavan as COO, Ross T. Ridenoure as Chief Nuclear Officer, and Dr. Andrew M. Ward as CTO. Additionally, nine directors were appointed to the board.

View raw filing on EDGAR →

Eloxx Pharmaceuticals, Inc. (ELOX)

8-K Exec appointment confidence 95% filed 2026-06-01 Item 5.02

The Board appointed Stephen W. Webster and Nina Kjellson as directors on May 27, 2026, filling vacancies and reducing board size from six to five members; both appointees were assigned to specific board committees and received equity grants of 13,587 option shares each.

View raw filing on EDGAR →

BCB BANCORP INC (BCBP)

8-K Exec appointment confidence 92% filed 2026-06-01 Item 5.02

Thomas M. O'Brien was appointed as President and Chief Executive Officer of BCB Bancorp, Inc. and BCB Community Bank effective June 1, 2026, with board service. While the filing also discloses compensatory arrangements (restricted stock grant of $8,000,000 value, base salary of $400,000, severance terms), the principal disclosed action is the appointment of a new principal executive officer. This is material to investors as it represents a significant leadership change at the company.

View raw filing on EDGAR →

SONIDA SENIOR LIVING, INC. (SNDA)

8-K Exec appointment confidence 95% filed 2026-06-01 Item 5.02

Anton Nikodemus was appointed as Executive Vice President and Chief Operating Officer, effective June 15, 2026, with a base salary of $550,000, performance bonus, equity awards, and severance provisions.

View raw filing on EDGAR →

Rapid7, Inc. (RPD)

8-K Exec appointment confidence 93% filed 2026-06-01 Item 5.02

Wael Mohamed was appointed Chief Executive Officer effective June 1, 2026, succeeding Corey Thomas who transitioned to Executive Chairman. The appointment includes compensatory arrangements including RSU grants, performance bonuses, and severance terms.

View raw filing on EDGAR →

NORFOLK SOUTHERN CORP (NSC)

8-K Exec appointment confidence 75% filed 2026-06-01 Item 5.02

Brian Barr was appointed as Chief Operating Officer, succeeding John Orr. The appointment includes detailed compensation terms including a $600,000 base salary, $2.5M long-term incentive plan target, $1.26M promotional award, and $2M retention bonus.

View raw filing on EDGAR →

BV Financial, Inc. (BVFL)

8-K Exec appointment confidence 92% filed 2026-06-01 Item 8.01

Timothy L. Prindle was elected Chairman of the Board in addition to his existing roles as President and CEO, representing a material change in executive leadership structure. The Board's deliberate decision to combine the Chairman and CEO roles, along with the concurrent appointment of William B. Crompton, III as Lead Independent Director to provide independent oversight, constitutes a significant governance event that would affect a reasonable investor's assessment of the company's leadership and control structure.

View raw filing on EDGAR →

Penguin Solutions, Inc. (PENG)

8-K Exec appointment confidence 85% filed 2026-06-01 Item 5.02

Aaron Johnson was appointed as interim CFO and principal financial and accounting officer of Penguin Solutions, Inc., effective July 9, 2026, succeeding Nate Olmstead who resigned from the CFO position effective July 8, 2026.

View raw filing on EDGAR →

VERRA MOBILITY Corp (VRRM)

8-K Exec appointment confidence 90% filed 2026-06-01 Item 5.02

Jonathan Keyser was appointed as Interim President and Chief Executive Officer of Verra Mobility Corp effective May 31, 2026, as disclosed via press release on June 1, 2026. This represents a material change in the Company's chief executive leadership.

View raw filing on EDGAR →

CORVEL CORP (CRVL)

8-K Exec appointment confidence 92% filed 2026-06-01 Item 5.02

Sarah Scott was appointed Chief Executive Officer and President of CorVel Corporation, effective July 1, 2026, with detailed compensation arrangements including a base salary of $600,000, bonus targets, and stock option grants, following Michael G. Combs' transition to Executive Chair.

View raw filing on EDGAR →

OCEANFIRST FINANCIAL CORP (OCFC)

8-K Exec appointment confidence 85% filed 2026-06-01 Item 5.02

OceanFirst appointed seven new directors effective June 1, 2026: six former Flushing Bank directors (Buran, DelliBovi, D'Iorio, Grassi, Han, Yoh) and Todd Schell designated by Warburg Pincus. John R. Buran was appointed Non-Executive Chairman, replacing Christopher D. Maher.

View raw filing on EDGAR →

Revium Rx. (RVRC)

8-K Exec appointment confidence 85% filed 2026-06-01 Item 5.02

The filing discloses both a CFO departure (Arie Gordashnikov) and an appointment (Igor Bluvstein) on the same date. The principal action emphasized is the appointment of Bluvstein as CFO, with detailed background on his 17+ years of financial leadership experience across multiple public companies (Argent BioPharma, G Medical Innovations, etc.). While a departure also occurred, the appointment is the forward-looking material event that would affect investor assessment of the company's financial leadership and governance.

View raw filing on EDGAR →

GULFPORT ENERGY CORP (GPOR)

8-K Exec appointment confidence 92% filed 2026-06-01 Item 5.02

Domenic J. Dell'Osso, Jr. was appointed as President and Chief Executive Officer effective May 28, 2026, and concurrently appointed to the Board of Directors. Dell'Osso brings over 20 years of energy industry experience, including prior service as CEO of Expand Energy/Chesapeake.

View raw filing on EDGAR →

MOZAYYX Acquisition Corp. (MZYX-WT)

8-K Exec appointment confidence 95% filed 2026-06-01 Item 5.02

The filing discloses the appointment of Emma Rose Bienvenu as an independent director of MOZAYYX Acquisition Corp., effective May 26, 2026. The disclosure includes her background, qualifications, and compensation arrangement (25,000 founder shares through the Sponsor). This is a clear executive appointment event, material to investors as it affects board composition and governance of a SPAC.

View raw filing on EDGAR →

Fusemachines Inc. (FUSEW)

8-K Exec appointment confidence 95% filed 2026-06-01

The filing discloses the appointment of Julia Hirschberg as a Class II director effective May 31, 2026, with concurrent appointments to the Audit Committee, Compensation Committee, and Nominating Committee, where she was named chair of the Compensation Committee. While the filing also mentions Sanjay Shrestha's resignation, the principal disclosed action centers on the appointment of a highly qualified new director (National Academy of Engineering member, AI/computer science expert) to multiple board committees, which is material to investors assessing board composition and governance.

View raw filing on EDGAR →

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

8-K Exec appointment confidence 95% filed 2026-06-01

The filing discloses the appointment of Stuart D. Porter to the Board of Directors effective May 29, 2026, under Item 5.02. Porter brings significant investment experience as Founder and CEO of Denham Capital with 29+ years in senior investment roles. This is a material board appointment for a biotechnology company, particularly given the reference to a "strategic transformation" in the press release disclosure, which suggests the appointment is part of a significant corporate initiative.

View raw filing on EDGAR →

Carlyle Group Inc. (CGABL)

8-K Exec appointment confidence 85% filed 2026-06-01 Item 5.02

Kate Heinzelman was appointed as General Counsel of Carlyle Group, effective June 29, 2026, a material officer position affecting corporate governance and legal strategy.

View raw filing on EDGAR →

Athene Holding Ltd. (ATH-PE)

8-K Exec appointment confidence 95% filed 2026-06-01 Item 5.02

Matthew Michelini was appointed President of Athene Holding Ltd., effective July 1, 2026. The appointment represents a material leadership transition, with Michelini bringing extensive experience from Apollo Global Management and prior board service at Athene.

View raw filing on EDGAR →

Lucid Group, Inc. (LCID)

8-K Exec appointment confidence 95% filed 2026-06-01 Item 5.02

Silvio Napoli was appointed as Chief Executive Officer of Lucid Group, Inc., effective June 1, 2026. Marc Winterhoff resumed the role of Chief Operating Officer as part of the leadership restructuring.

View raw filing on EDGAR →

REGAL REXNORD CORP (RRX)

8-K Exec appointment confidence 75% filed 2026-06-01 Item 5.02

While the disclosure centers on Jerry Morton's retirement effective December 31, 2026, the principal action disclosed is the appointment of Mark Klossner as Executive Vice President & President, Industrial Powertrain Solutions, effective June 1, 2026. The filing emphasizes Klossner's appointment and his transition into the role, making this an executive appointment event. The retirement is contextual to the succession plan rather than the primary focus.

View raw filing on EDGAR →